336 results on '"Katagiri, Yuki"'
Search Results
2. Geographic disparity of pathophysiological coronary artery disease characteristics: Insights from ASET trials
3. TAV-in-TAV for paravalvular aortic regurgitation due to a deeply implanted Navitor transcatheter aortic valve
4. Three-dimensional image reconstruction of a thermoplastic rod burning with and without melting
5. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022
6. A Prospective Multicenter Randomized Trial to Assess the Effectiveness of the MagicTouch Sirolimus-Coated Balloon in Small Vessels: Rationale and Design of the TRANSFORM I Trial
7. Endothelial shear stress and vascular remodeling in bioresorbable scaffold and metallic stent
8. Arbitrary Polynomial Chaos Based Simulation of Probabilistic Power Flow Including Renewable Energies
9. Fate of Box Fracture of Calcified Plaque After Intravascular Lithotripsy
10. Impella 5.5 Placement Across Evolut FX Transcatheter Aortic Valve: Balloon-Assisted Procedure
11. The neuromodulatory role of dopamine in improved reaction time by acute cardiovascular exercise
12. Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease
13. Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel Disease
14. TCT-317 Acute Results of Optical Coherence Tomography-Guided Percutaneous Coronary Intervention With Intravascular Lithotripsy Versus Orbital/Rotational Atherectomy in Calcified Lesions: A Propensity-Matched Comparison
15. TCT-600 Evaluation of the Stent Parameters Post-PCI (Minimum Stent Area, Stent Expansion Index, and Stent Gradient) and its Relation to Post-PCI Physiological Outcomes Assessed by Intravascular Imaging-Based Ultrasonic Flow Ratio and Optical Flow Ratio: Insights From the ASET JAPAN Trial
16. Reduced-dose prasugrel monotherapy without aspirin after PCI with the SYNERGY stent in East Asian patients presenting with chronic coronary syndromes or non-ST-elevation acute coronary syndromes: rationale and design of the ASET Japan pilot study
17. Left Main Coronary Artery Embolism after Transcatheter Aortic Valve Replacement: Insights from Multimodal Intracoronary Imagings
18. Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD
19. A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial
20. Coronary calcification as a mechanism of plaque/media shrinkage in vessels treated with bioresorbable vascular scaffold: A multimodality intracoronary imaging study
21. The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial
22. Post-implantation shear stress assessment: an emerging tool for differentiation of bioresorbable scaffolds
23. TAV-in-TAV for paravalvular aortic regurgitation due to a deeply implanted Navitor transcatheter aortic valve
24. A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) in Brazil and Japan: Synergy Stent with Prasugrel Monotherapy Without Aspirin
25. A Randomized Trial Evaluating Online 3-Dimensional Optical Frequency Domain Imaging–Guided Percutaneous Coronary Intervention in Bifurcation Lesions
26. Impact of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography on Heart Team Treatment Decision-Making in Patients With Multivessel Coronary Artery Disease: Insights From the SYNTAX III REVOLUTION Trial
27. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018
28. TCTAP A-046 A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) In Brazil and Japan: Synergy Stent With Prasugrel Monotherapy Without Aspirin
29. Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN)
30. CRT-100.33 A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) in Brazil and Japan: Synergy Stent with Prasugrel Monotherapy Without Aspirin
31. Imaging assessment of bioresorbable vascular scaffolds
32. Single or dual antiplatelet therapy after PCI
33. Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation
34. Artificial Intelligence vs Visual Assessment of Calcified Plaque in Coronary Artery Using Optical Coherence Tomography
35. TCT-251 Artificial Intelligence Versus Visual Assessment of Calcified Plaque in Coronary Artery Using Optical Coherence Tomography
36. TCT-14 A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) After PCI in Brazil and Japan: SYNERGY Stent With Prasugrel Monotherapy (10 mg or 3.75 mg)
37. Impact of Coronary Remodeling on Fractional Flow Reserve
38. Emerging technologies: Overview of the field
39. Revisiting the Aortic Valve Calcium Score in Evaluating the Severity of Aortic Stenosis in Japanese Patients ― A Single-Center Study ―
40. Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial
41. Investigation of the role and quantitative impact of breast cancer resistance protein on drug distribution into brain and CSF in rats
42. Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial: Online 3D OFDI-guided bifurcation PCI
43. The Influence of Implantation Techniques on Lesion-Oriented Outcomes in Absorb BVS and Xience EES Lesions Treated in Routine Clinical Practice at Complete Three-Year Follow-Up - AIDA Trial QCA Substudy
44. Expert recommendations on the assessment of wall shear stress in human coronary arteries: existing methodologies, technical considerations, and clinical applications
45. 16 - Bioresorbable Coronary Scaffolds
46. Risk Factors and Outcomes of Recurrent Drug‐Eluting Stent Thrombosis: Insights From the REAL‐ST Registry
47. Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial
48. Vulnerable plaques and patients: state-of-the-art
49. Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials
50. Judicial Precedents on Social Security Law and Japanese Constitution Article 25
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.